Fidelity Investments
RVMD icon

Fidelity Investments’s Revolution Medicines RVMD Stock Holding History

Fidelity Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28B Buy
12,200,422
+3,736,108
+44% +$546M 0.1% 159
2026
Q1 		$823M Sell
8,464,314
-123,667
-1% -$12.5M 0.04% 346
2025
Q4 		$684M Sell
8,587,981
-813,706
-9% -$53.4M 0.03% 400
2025
Q3 		$439M Buy
9,401,687
+1,076,503
+13% +$42.1M 0.02% 555
2025
Q2 		$306M Buy
8,325,184
+789,413
+10% +$30.3M 0.02% 660
2025
Q1 		$266M Buy
7,535,771
+793,688
+12% +$32.2M 0.02% 686
2024
Q4 		$295M Buy
6,742,083
+866,190
+15% +$43.7M 0.02% 665
2024
Q3 		$266M Buy
5,875,893
+250,037
+4% +$10.9M 0.02% 720
2024
Q2 		$218M Buy
5,625,856
+1,459,091
+35% +$54.5M 0.01% 755
2024
Q1 		$134M Buy
4,166,765
+2,615
+0.1% +$77.5K 0.01% 944
2023
Q4 		$119M Buy
4,164,150
+3,465,332
+496% +$83.3M 0.01% 942
2023
Q3 		$19.3M Buy
698,818
+116,106
+20% +$3.44M ﹤0.01% 1592
2023
Q2 		$15.6M Sell
582,712
-15,959
-3% -$392K ﹤0.01% 1730
2023
Q1 		$13M Buy
598,671
+168,904
+39% +$4.16M ﹤0.01% 1774
2022
Q4 		$10.2M Sell
429,767
-2,983
-0.7% -$63.4K ﹤0.01% 1878
2022
Q3 		$8.53M Buy
432,750
+367,197
+560% +$8.07M ﹤0.01% 1973
2022
Q2 		$1.28M Sell
65,553
-2,801,467
-98% -$54.5M ﹤0.01% 2619
2022
Q1 		$73.1M Sell
2,867,020
-3,234,704
-53% -$70.4M 0.01% 1220
2021
Q4 		$154M Sell
6,101,724
-1,696,160
-22% -$47.8M 0.01% 904
2021
Q3 		$215M Sell
7,797,884
-1,736,375
-18% -$50.5M 0.02% 776
2021
Q2 		$303M Sell
9,534,259
-1,297,986
-12% -$45.3M 0.02% 648
2021
Q1 		$497M Buy
10,832,245
+1,492,760
+16% +$66.9M 0.04% 437
2020
Q4 		$370M Sell
9,339,485
-549,476
-6% -$21.7M 0.03% 494
2020
Q3 		$344M Buy
9,888,961
+1,985,236
+25% +$55M 0.03% 428
2020
Q2 		$248M Buy
7,903,725
+1,239,662
+19% +$39M 0.03% 523
2020
Q1 		$144M Buy
+6,664,063
New +$184M 0.02% 622

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments's RVMD Position: Q2 2026 in Review

Fidelity Investments increased its Revolution Medicines (RVMD) stake by 44% in Q2 2026, buying an estimated $546M and bringing the position to 12,200,422 shares worth $2.28B. The position accounts for 0.1% of the portfolio, ranked #159.

Fidelity Investments first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Fidelity Investments held 12,200,422 shares of Revolution Medicines worth $2.28B as of Q2 2026.
  • Fidelity Investments bought 3,736,108 Revolution Medicines shares in Q2 2026, an estimated $546M.
  • Revolution Medicines made up 0.1% of Fidelity Investments's portfolio in Q2 2026, its #159 holding.
  • Fidelity Investments first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.